This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Jul 26;357(4):380-90.

doi: 10.1056/NEJMcp070747.

Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

Robert S Daum¹

Affiliations

PMID: 17652653
DOI: 10.1056/NEJMcp070747

Review

Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

Robert S Daum. N Engl J Med. 2007.

. 2007 Jul 26;357(4):380-90.

doi: 10.1056/NEJMcp070747.

Author

Robert S Daum¹

Affiliation

¹ Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, USA.

PMID: 17652653
DOI: 10.1056/NEJMcp070747

Erratum in

N Engl J Med. 2007 Sep 27;357(13):1357. Dosage error in article text

No abstract available

PubMed Disclaimer

Comment in

Methicillin-resistant Staphylococcus aureus infections.
Abrahamian FM, Moran GJ. Abrahamian FM, et al. N Engl J Med. 2007 Nov 15;357(20):2090; author reply 2090. doi: 10.1056/NEJMc072407. N Engl J Med. 2007. PMID: 18003971 No abstract available.

Similar articles

Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
da Silva LV, Zavascki AP, de Souza MV, Marcadenti A. da Silva LV, et al. Am J Surg. 2008 Oct;196(4):618-9. doi: 10.1016/j.amjsurg.2007.12.046. Am J Surg. 2008. PMID: 18809069 No abstract available.
Variability among pediatric infectious diseases specialists in the treatment and prevention of methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Creech CB, Beekmann SE, Chen Y, Polgreen PM. Creech CB, et al. Pediatr Infect Dis J. 2008 Mar;27(3):270-2. doi: 10.1097/INF.0b013e31815c9068. Pediatr Infect Dis J. 2008. PMID: 18277924
Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Widmer AF. Widmer AF. Clin Infect Dis. 2008 Mar 1;46(5):656-8. doi: 10.1086/526528. Clin Infect Dis. 2008. PMID: 18225983 Review. No abstract available.
Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Whitman TJ. Whitman TJ. Dis Mon. 2008 Dec;54(12):780-6. doi: 10.1016/j.disamonth.2008.09.010. Dis Mon. 2008. PMID: 18996280 Review. No abstract available.
Emerging drugs for complicated skin and skin-structure infections.
Mendoza N, Tyring SK. Mendoza N, et al. Expert Opin Emerg Drugs. 2010 Sep;15(3):509-20. doi: 10.1517/14728214.2010.497486. Expert Opin Emerg Drugs. 2010. PMID: 20557269 Review.

See all similar articles

Cited by

Efficacy and Safety of Antibiotics in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: A Systematic Review and Network Meta-Analysis.
Liu Q, He D, Wang L, Wu Y, Liu X, Yang Y, Chen Z, Dong Z, Luo Y, Song Y. Liu Q, et al. Antibiotics (Basel). 2024 Sep 10;13(9):866. doi: 10.3390/antibiotics13090866. Antibiotics (Basel). 2024. PMID: 39335039 Free PMC article. Review.
Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections.
Zhu J, Xie R, Gao R, Zhao Y, Yodsanit N, Zhu M, Burger JC, Ye M, Tong Y, Gong S. Zhu J, et al. Nat Nanotechnol. 2024 Jul;19(7):1032-1043. doi: 10.1038/s41565-024-01648-8. Epub 2024 Apr 17. Nat Nanotechnol. 2024. PMID: 38632494
The chemerin-CMKLR1 axis in keratinocytes impairs innate host defense against cutaneous Staphylococcus aureus infection.
Chen Y, Song Y, Wang Z, Lai Y, Yin W, Cai Q, Han M, Cai Y, Xue Y, Chen Z, Li X, Chen J, Li M, Li H, He R. Chen Y, et al. Cell Mol Immunol. 2024 Jun;21(6):533-545. doi: 10.1038/s41423-024-01152-y. Epub 2024 Mar 26. Cell Mol Immunol. 2024. PMID: 38532043
Antimicrobial activity of a natural compound and analogs against multi-drug-resistant Gram-positive pathogens.
Shah KN, Shah PN, Agobe FO, Lovato K, Gao H, Ogun O, Hoffman C, Yabe-Gill M, Chen Q, Sweatt J, Chirra B, Muñoz-Medina R, Farmer DE, Kürti L, Cannon CL. Shah KN, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0151522. doi: 10.1128/spectrum.01515-22. Epub 2024 Jan 30. Microbiol Spectr. 2024. PMID: 38289721 Free PMC article.
Inhibition of α-hemolysin activity of Staphylococcus aureus by theaflavin 3,3'-digallate.
Goc A, Sumera W, Rath M, Niedzwiecki A. Goc A, et al. PLoS One. 2023 Aug 31;18(8):e0290904. doi: 10.1371/journal.pone.0290904. eCollection 2023. PLoS One. 2023. PMID: 37651426 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information